Altitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered by the National Institutes of Health. Accepted applicants will be admitted to Altitude Lab, the Salt Lake City biotech accelerator formed by Recursion Pharmaceuticals.
The post Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult appeared first on MedCity News.
Leave a comment